Synthesis of Novel 2-Thiouracil-5-Sulfonamide Derivatives as Potent Inducers of Cell Cycle Arrest and CDK2A Inhibition Supported by Molecular Docking |
| |
| Authors: | Samar S Fatahala Amira I Sayed Shahenda Mahgoub Heba Taha Mohamed-I kotb El-Sayed Mohamed F El-Shehry Samir M Awad Rania H Abd El-Hameed |
| |
| Affiliation: | 1.Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Helwan 11795, Egypt; (A.I.S.); (S.M.A.); (R.H.A.);2.Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Helwan 11795, Egypt; (S.M.); (H.T.); (M.K.E.-S.);3.Pesticide Chemistry Department, National Research Centre, Dokki 12622, Egypt; |
| |
| Abstract: | In an effort to discover potent anticancer agents, 2-thiouracil-5-sulfonamides derivatives were designed and synthesized. The cytotoxic activity of all synthesized compounds was investigated against four human cancer cell lines viz A-2780 (ovarian), HT-29 (colon), MCF-7 (breast), and HepG2 (liver). Compounds 6b,d–g, and 7b showed promising anticancer activity and significant inhibition of CDK2A. Moreover, they were all safe when tested on WI38 normal cells with high selectivity index for cancer cells. Flow cytometric analysis for the most active compound 6e displayed induction of cell growth arrest at G1/S phase (A-2780 cells), S phase (HT-29 and MCF-7 cells), and G2/M phase (HepG2 cells) and stimulated the apoptotic death of all cancer cells. Moreover, 6e was able to cause cycle arrest indirectly through enhanced expression of cell cycle inhibitors p21 and p27. Finally, molecular docking of compound 6e endorsed its proper binding to CDK2A, which clarifies its potent anticancer activity. |
| |
| Keywords: | sulfonamides cytotoxicity apoptosis cell cycle CDK2 molecular docking |
|
|
